Log in to save to my catalogue

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblast...

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblast...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10043273

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma

About this item

Full title

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma

Publisher

Singapore: Springer Nature Singapore

Journal title

Acta pharmacologica Sinica, 2023-04, Vol.44 (4), p.877-887

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

Neuroblastoma is the most common and deadliest tumor in infancy. WDR5 (WD Repeat Domain 5), a critical factor supporting an N-myc transcriptional complex via its WBM site and interacting with chromosome via its WIN site, promotes the progression of neuroblastoma, thus making it a potential anti-neuroblastoma drug target. So far, a few WIN site inhi...

Alternative Titles

Full title

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10043273

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10043273

Other Identifiers

ISSN

1671-4083

E-ISSN

1745-7254

DOI

10.1038/s41401-022-00999-z

How to access this item